ENTITY

Otonomy Inc (OTIC US)

Health Care • United States

Otonomy, Inc. operates as a clinical stage biopharmaceutical company. The Company develops therapeutics for treatment of inner and middle ear disorders.

Refresh

Company Event • 25 Jul 2023 00:30 • Upcoming

Add To Calendar

Q2 2023

Company Event • 26 Jun 2023 20:00 • Upcoming

Add To Calendar

Q1 2023

Company Event • 10 Nov 2022 20:00 • Upcoming

Add To Calendar

Q3 2022

Company Event • 26 Jul 2022 00:30 • Latest

Q2 2022

No more events

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00